James Kasinger

(Mr. James Kasinger J.D.)

Currently holds a position at CRISPR Therapeutics AG

Positions

Position Company Period
General Counsel, Secretary CRISPR Therapeutics AG May 1, 2017 -
James Kasinger's trades of CRISPR Therapeutics AG's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-24 2025-03-21
S Sale
3,185 -3.8%
41.23
USD 131,318 		3,185 -3.8% 41.23 USD 131,318
2025-03-12 2025-03-12
S Sale
1,116 -1.4%
43.32
USD 48,345 		1,116 -1.4% 43.32 USD 48,345
2025-03-12 2025-03-11
S Sale
2,850 -3.5%
42.42
USD 120,897 		2,850 -3.5% 42.42 USD 120,897
2025-02-19 2025-02-19
S Sale
1,947 -2.5%
52.80
USD 102,802 		1,947 -2.5% 52.80 USD 102,802
2025-02-19 2025-02-18
S Sale
9,595 -11.6%
53.85
USD 516,691 		9,595 -11.6% 53.85 USD 516,691
2024-10-15 2024-10-14
S Sale
1,089 -1.7%
46.28
USD 50,399 		1,089 -1.7% 46.28 USD 50,399
2024-03-12 2024-03-12
S Sale
1,146 -1.8%
74.44
USD 85,308 		1,146 -1.8% 74.44 USD 85,308
2024-03-12 2024-03-11
S Sale
2,801 -4.5%
78.26
USD 219,206 		2,801 -4.5% 78.26 USD 219,206
2024-02-21 2024-02-20
S Sale
1,913 -3.2%
79.67
USD 152,409 		1,913 -3.2% 79.67 USD 152,409
2021-01-20 2021-01-19
PS Planned sale
2,100 -8.6%
207.61
USD 435,981 		2,100 -8.6% 207.61 USD 435,981
2021-01-20 2021-01-19
PS Planned sale
1,800 -6.8%
206.05
USD 370,890 		1,800 -6.8% 206.05 USD 370,890
2021-01-20 2021-01-19
PS Planned sale
8,997 -25.5%
205.60
USD 1,849,783 		8,997 -25.5% 205.60 USD 1,849,783
2021-01-20 2021-01-19
PS Planned sale
7,818 -18.1%
204.40
USD 1,597,999 		7,818 -18.1% 204.40 USD 1,597,999
2021-01-20 2021-01-19
PS Planned sale
6,785 -13.6%
203.58
USD 1,381,290 		6,785 -13.6% 203.58 USD 1,381,290
// ... existing code ... // ... rest of the file ...